Status:
UNKNOWN
Individual Determinants of Postprandial Glucose Response in Type 2 Diabetes
Lead Sponsor:
Federico II University
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
Postprandial glycemia (PPG) is a relevant determinant of glucose control in people with type 2 diabetes (T2D). Epidemiological and pathophysiological studies indicate that PPG is a better risk predict...
Detailed Description
The participants will undergo a 7-day observational period and acute postprandial tests with a standardized meal. Before the study initiation, all participants will undergo a screening visit for the a...
Eligibility Criteria
Inclusion
- Men and post-menopausal women
- HbA1c ≤ 7.5%
- Body Mass Index (BMI) 20-39.9 kg/m2
- Ability to comply with the study protocol activities.
Exclusion
- Any acute or chronic condition possibly influencing the interpretation of the results or possibly worsened because of study participation
- Pregnancy or breast-feeding
- Use of antibiotics, probiotics, or prebiotics during the last three months.
Key Trial Info
Start Date :
May 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2025
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT06057246
Start Date
May 15 2023
End Date
May 1 2025
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical Medicine and Surgery Federico II University
Naples, Italy, 80131